222. Primary nephrotic syndrome Clinical trials / Disease details

Clinical trials : 310 / Drugs : 295 - (DrugBank : 117) / Drug target genes : 63 - Drug target pathways : 194

5 trials found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	ChiCTR-IPR-17011702	2017-07-01	2017-06-19	Compare of the treatment of membranous nephropathy with mizoribine and steroid or cyclophosphamide and steroid	Compare of the treatment of membranous nephropathy with mizoribine and steroid or cyclophosphamide and steroid	membranous nephropathy	mizoribine group:treated with mizoribine and steroid;cyclophosphamide group:treated with cyclophosphamide and steroid;	Tianjin First Central Hospital	NULL	Pending	18	65	Both	mizoribine group:50;cyclophosphamide group:50;		China
2	JPRN-UMIN000008919	2012/09/15	14/09/2012	The prospective multi-center study on the efficacy and safety of mizoribine for the treatment of aged nephrotic patients with primary membranous nephropathy.	The prospective multi-center study on the efficacy and safety of mizoribine for the treatment of aged nephrotic patients with primary membranous nephropathy. - The study on efficacy and safety of mizoribine for the aged patients with membranous nephropathy.	The patients with nephrotic syndrome due to primary membranous nephropathy.	Treatment with a combination of mizoribine plus steroid therapy Treatment with steroid monotherapy	The study group of treatment for aged patients with nephrotic syndrome.	NULL	Complete: follow-up complete	65years-old	Not applicable	Male and Female	200	Not applicable	Japan
3	JPRN-C000000158	2006/03/01	01/04/2006	Mizoribin for primary nephrotic syndrome in children(JSRDC09)	Mizoribin for primary nephrotic syndrome in children(JSRDC09) - Mizoribin for primary nephrotic syndrome in children(JSRDC09)	Steroid-sensitive nephrotic syndrome	mizoribine+prednisolone	Japanese Study Group of Renal Disease in Children(JSRDC)	NULL	Complete: follow-up complete	1years-old	10years-old	Male and Female	50	Not selected	Japan
4	JPRN-C000000368	2004/04/01	27/03/2006	Multicenter study for combined therapy of prednisolone and mizoribine in idiopathic membranous nephropathy with refractory nephrotic syndrome	Multicenter study for combined therapy of prednisolone and mizoribine in idiopathic membranous nephropathy with refractory nephrotic syndrome - Combined therapy of prednisolone and mizoribine in membranous nephropathy with refractory nephrotic syndrome	membranous nephropathy with primary steroid resistant nephrotic syndrome	mizoribine once a day per os administration (150mg) after breakfast for 2years. mizoribine 3 times a day per os administration (50mg each) after meals for 2years.	Project team for treatment of refractory nephrotic syndrome	The Progressive Renal Disease Research Projects in the Ministry of Health, Labor and Welfare, Japan	Complete: follow-up complete	16years-old	75years-old	Male and Female	100	Not selected	Japan
5	JPRN-C000000379	2001/04/01	01/04/2006	Prednisolone only and a combination of prednisolone and mizoribine for primary nephrotic syndrome relapsed within six mounths after first onset in children: A randomized controlled trial of efficacy and safety (JSRDC06)	Prednisolone only and a combination of prednisolone and mizoribine for primary nephrotic syndrome relapsed within six mounths after first onset in children: A randomized controlled trial of efficacy and safety (JSRDC06) - Prednisolone only and a combination of prednisolone and mizoribine for primary nephrotic syndrome in children: A randomized controlled trial (JSRDC06)	Steroid-sensitive nephrotic syndrome	prednisolone mizoribine+prednisolone	Japanese Study Group of Renal Disease in Children(JSRDC)	NULL	Complete: follow-up complete	1years-old	10years-old	Male and Female	50	Not selected	Japan